Cargando…

DOCK8 regulates protective immunity by controlling the function and survival of RORγt(+) ILCs

Retinoic-acid receptor-related orphan receptor-γt-positive (RORγt(+)) innate lymphoid cells (ILCs) produce interleukin (IL)-22 and IL-17, which are critical for protective immunity against enteric pathogens. The molecular mechanism underlying the development and survival of RORγt(+) ILCs is not thor...

Descripción completa

Detalles Bibliográficos
Autores principales:	Singh, Akhilesh K., Eken, Ahmet, Fry, Mallory, Bettelli, Estelle, Oukka, Mohamed
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2014
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4135384/ https://www.ncbi.nlm.nih.gov/pubmed/25091235 http://dx.doi.org/10.1038/ncomms5603

Ejemplares similares

S1P(1) deletion differentially affects TH17 and Regulatory T cells
por: Eken, Ahmet, et al.
Publicado: (2017)

Astragalus regulates the intestinal immune response during sepsis by mediating ILC3 proliferation through RORγt
por: Li, Jin, et al.
Publicado: (2023)

Digoxin, an Overlooked Agonist of RORγ/RORγT
por: Karaś, Kaja, et al.
Publicado: (2019)

Trypanosoma cruzi trans-sialidase initiates an ROR-γt–AHR-independent program leading to IL-17 production by activated B cells
por: Bermejo, Daniela A, et al.
Publicado: (2013)

The Th17 immune response is controlled by the Rel–RORγ–RORγT transcriptional axis
por: Ruan, Qingguo, et al.
Publicado: (2011)

Single-cell analysis of RORα tracer mouse lung reveals ILC progenitors and effector ILC2 subsets
por: Ghaedi, Maryam, et al.
Publicado: (2019)

CCR7-dependent trafficking of RORγ(+) ILCs creates a unique microenvironment within mucosal draining lymph nodes
por: Mackley, Emma C., et al.
Publicado: (2015)

Ets-1 is a negative regulator of Th17 differentiation
por: Moisan, Jacques, et al.
Publicado: (2007)

Transcription factor T-bet represses T(H)17 differentiation by preventing Runx1-mediated activation of the RORγt gene
por: Lazarevic, Vanja, et al.
Publicado: (2010)

The Dichotomous Nature of AZ5104 (an EGFR Inhibitor) Towards RORγ and RORγT
por: Karaś, Kaja, et al.
Publicado: (2019)

Corrigendum: CCR7-dependent trafficking of RORγ(+) ILCs creates a unique microenvironment within mucosal draining lymph nodes
por: Mackley, Emma C., et al.
Publicado: (2016)

RORγt phosphorylation protects against T cell-mediated inflammation
por: Ma, Shengyun, et al.
Publicado: (2022)

The application of machine learning methods to the prediction of novel ligands for RORγ/RORγT receptors
por: Bachorz, Rafał A., et al.
Publicado: (2023)

IL-23 Promotes TCR-mediated Negative Selection of Thymocytes through the Upregulation of IL-23 Receptor and RORγt
por: Li, Hao, et al.
Publicado: (2014)

RORα is a critical checkpoint for T cell and ILC2 commitment in the embryonic thymus
por: Ferreira, Ana C. F., et al.
Publicado: (2021)

RORα and RORγ expression inversely correlates with human melanoma progression
por: Brożyna, Anna A., et al.
Publicado: (2016)

RORγt and RORα signature genes in human Th17 cells
por: Castro, Glenda, et al.
Publicado: (2017)

RORγ Structural Plasticity and Druggability
por: Huang, Mian, et al.
Publicado: (2020)

Silencing RORγt in Human CD4(+) T cells with CD30 aptamer-RORγt shRNA Chimera
por: Shi, Xiaofei, et al.
Publicado: (2019)

Zbtb1 controls NKp46(+) ROR-gamma-T(+) innate lymphoid cell (ILC3) development
por: Lu, Ying, et al.
Publicado: (2017)

Identification of an allosteric binding site for RORγt inhibition
por: Scheepstra, Marcel, et al.
Publicado: (2015)

Campylobacter infection promotes IFNγ-dependent intestinal pathology via ILC3 to ILC1 conversion
por: Muraoka, Wayne T., et al.
Publicado: (2020)

Synthetic RORγ agonists regulate multiple pathways to enhance antitumor immunity
por: Hu, Xiao, et al.
Publicado: (2016)

The therapeutic potential of RORγ modulators in the treatment of human disease
por: Chang, Mi Ra, et al.
Publicado: (2012)

Effects of RORγt overexpression on the murine central nervous system
por: Sasaki, Tetsuya, et al.
Publicado: (2021)

Identification of RORγ as a favorable biomarker for colon cancer
por: Pan, Xiaofei, et al.
Publicado: (2021)

Preclinical and clinical characterization of the RORγt inhibitor JNJ-61803534
por: Xue, Xiaohua, et al.
Publicado: (2021)

An inhibitor of RORγ for chronic pulmonary obstructive disease treatment
por: Desai, Harshada, et al.
Publicado: (2022)

Expression of Th-17 and RORγt mRNA in Behçet’s Disease
por: Hamzaoui, Kamel, et al.
Publicado: (2011)

Involvement of RORγt-overexpressing T cells in the development of autoimmune arthritis in mice
por: Kondo, Yuya, et al.
Publicado: (2015)

Sumoylation of RORγt regulates T(H)17 differentiation and thymocyte development
por: He, Zhiheng, et al.
Publicado: (2018)

Cooperativity between the orthosteric and allosteric ligand binding sites of RORγt
por: de Vries, Rens M. J. M., et al.
Publicado: (2021)

Intestinal factors promoting the development of RORγt(+) cells and oral tolerance
por: López-Fandiño, Rosina, et al.
Publicado: (2023)

SUMOylation of ROR-γt inhibits IL-17 expression and inflammation via HDAC2
por: Singh, Amir Kumar, et al.
Publicado: (2018)

ILC
por: Stanitzki, Marcel
Publicado: (2018)

Targeting the ROR1 and ROR2 receptors in epithelial ovarian cancer inhibits cell migration and invasion
por: Henry, Claire, et al.
Publicado: (2015)

Transcription of RORγt in Developing Th17 Cells is Regulated by E-Proteins
por: Zhang, Fuping, et al.
Publicado: (2013)

SIRT1 deacetylates RORγt and enhances Th17 cell generation
por: Lim, Hyung W., et al.
Publicado: (2015)

The Nuclear Receptor, RORγ, Regulates Pathways Necessary for Breast Cancer Metastasis
por: Oh, Tae Gyu, et al.
Publicado: (2016)

Reciprocal regulation of RORγt acetylation and function by p300 and HDAC1
por: Wu, Qingsi, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_afs777o90abnlsj5bv6o4qvcc7